Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment
- PMID: 18308942
- DOI: 10.1634/stemcells.2007-1072
Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment
Abstract
The application of mesenchymal stem cells (MSCs) for myocardial repair following ischemic injury is of strong interest, but current knowledge regarding the survival and retention of differentiation potency of stem cells under ischemic conditions is limited. The present study investigated the effects of ischemia and its components (hypoxia and glucose depletion) on MSC viability and multipotency. We demonstrate that MSCs have a profoundly greater capacity to survive under conditions of ischemia compared with cardiomyocytes, measured by detecting changes in cellular morphology, caspase activity and phosphatidylserine exposure. MSCs were also resistant to exposure to hypoxia (0.5% O(2)), as well as inhibition of mitochondrial respiration with 2,4-dinitrophenol for 72 hours, indicating that in the absence of oxygen, MSCs can survive using anaerobic ATP production. Glucose deprivation (glucose-free medium in combination with 2-deoxyglucose) induced rapid death of MSCs. Depletion of cellular ATP occurred at a lower rate during glucose deprivation than during ischemia, suggesting that glycolysis has specific prosurvival functions, independent of energy production in MSCs. After exposure to hypoxic or ischemic conditions, MSCs retained the ability to differentiate into chondrocytes and adipocytes and, more importantly, retained cardiomyogenic potency. These results suggest that MSCs are characterized by metabolic flexibility, which enables them to survive under conditions of ischemic stress and retain their multipotent phenotype. These results highlight the potential utility of MSCs in the treatment of ischemic disease.
Similar articles
-
Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.Thorac Cardiovasc Surg. 2010 Apr;58(3):136-42. doi: 10.1055/s-0029-1240758. Thorac Cardiovasc Surg. 2010. PMID: 20379963
-
Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.Stem Cells. 2009 Jun;27(6):1358-65. doi: 10.1002/stem.47. Stem Cells. 2009. PMID: 19489098
-
Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.J Am Coll Cardiol. 2008 Mar 4;51(9):933-43. doi: 10.1016/j.jacc.2007.11.040. J Am Coll Cardiol. 2008. PMID: 18308163 Clinical Trial.
-
The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases.Biochem Biophys Res Commun. 2007 Jul 27;359(2):189-93. doi: 10.1016/j.bbrc.2007.05.112. Epub 2007 May 25. Biochem Biophys Res Commun. 2007. PMID: 17543286 Review.
-
Trafficking and differentiation of mesenchymal stem cells.J Cell Biochem. 2009 Apr 15;106(6):984-91. doi: 10.1002/jcb.22091. J Cell Biochem. 2009. PMID: 19229871 Review.
Cited by
-
Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers.Stem Cell Rev Rep. 2021 Aug;17(4):1343-1361. doi: 10.1007/s12015-021-10165-3. Epub 2021 Apr 16. Stem Cell Rev Rep. 2021. PMID: 33864233 Review.
-
IRX5 promotes adipogenesis of hMSCs by repressing glycolysis.Cell Death Discov. 2022 Apr 15;8(1):204. doi: 10.1038/s41420-022-00986-7. Cell Death Discov. 2022. PMID: 35428362 Free PMC article.
-
NGF protects bone marrow mesenchymal stem cells against 2,5-hexanedione-induced apoptosis in vitro via Akt/Bad signal pathway.Mol Cell Biochem. 2019 Jul;457(1-2):133-143. doi: 10.1007/s11010-019-03518-7. Epub 2019 Mar 25. Mol Cell Biochem. 2019. PMID: 30911955
-
Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.Biomaterials. 2014 Aug;35(25):6850-6858. doi: 10.1016/j.biomaterials.2014.04.114. Epub 2014 May 23. Biomaterials. 2014. PMID: 24862441 Free PMC article.
-
Proteomic analysis of fibroblastema formation in regenerating hind limbs of Xenopus laevis froglets and comparison to axolotl.BMC Dev Biol. 2014 Jul 25;14:32. doi: 10.1186/1471-213X-14-32. BMC Dev Biol. 2014. PMID: 25063185 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources